Tuesday, August 4, 2026

Over 32,000 Attacks on South Korean Diplomatic Sites from China

Recent data shows that South Korean diplomatic institutions faced the most cyber attacks from China, with over 32,000 attempts reported.

2024 Election Scandal: Special Investigation Team Questions Ex-Intelligence Chief

Former intelligence chief Noh Sang-won faces questioning over allegations of organizing a criminal group tied to election fraud.

Samsung Crowned #1 Home Entertainment Brand—19 Years and Counting

Samsung Electronics has been named the 2025 Home Entertainment Brand of the Year, recognized for its technology and design excellence.

Tag: glucagon

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

MetaVia to Present DA-1726 Phase 1 Obesity Trial Data at EASL Congress 2026

Dong-A ST's Meta via will present DA-1726, a dual-action obesity treatment, at the EASL Congress 2026, showcasing promising clinical trial results.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.